May 3rd, 2016
During the turbulent first quarter of 2016, graduates from the top MBA programs capitalized on opportunities to trim their stock holdings, raising billions of dollars of cash in the process. According to a recent analysis of Donor Watch's MBA Graduate Prospect Research List, the top MBAs sold nearly $2.7 billion in stock during Q1 2016.

Topping the list with the largest stocks sales by their MBA alumni are the Harvard Business School, the University of Pennsylvania' Wharton School and the University of Chicago's Booth School. Combined, alumni from the three top business schools sold nearly $700M in stock during Q1.

Overall, HBS's top selling alumni sold more than $310 million worth of stock during Q1, with Alan Lafley (Chairman of Procter & Gamble / PG), Martin Roper (CEO of Boston Beer / SAM), Marc Casper (CEO of Thermo Fisher Scientific / TMO), and Gregory Case (CEO of Aon Corp / AON) leading the list.

The Wharton School's alumni sold more the $250 million worth of equities, with Safra Catz (CEO of Oracle / ORCL), Jay Fishman (Chairman of the Travelers Companies / TRV), John Bryant (Chairman of Kellogg Company and Jean Jacques Bienaime (CEO of Biomarin Pharmaceutical / BMRN) leading the alums.

The other MBA program's that made the top 10 prospect list are Columbia Business School, NYU Stern, Northwestern University's Kellogg, Stanford Graduate School of Business, UCLA's Anderson School, Berkeley's Haas School and Cornell's Johnson School.

Some smaller MBA programs also pushed their way into the top 20 list of MBA schools, including: Atlanta University, College of William and Mary, Golden Gate University, Monmouth University, Santa Clara University and Xavier University.

Donor Watch provides its powerful software platform and real-time analyses to the development offices and prospect research teams at leading colleges, universities and nonprofits. Donor Watch's unique and robust set of research tools empower fund raisers and prospect researchers to manage their relationships with top and high potential donors.  For more information and access, please sign-up for a free trial today.